| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |